← Open Payments lookup

REBECCA KOOPMAN: Open Payments

NPI 1043883259 · SCOTTSBURG, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$653 in 38 payments from 12 companies in 2025. Trend: 2023 $142 · 2024 $335 · 2025 $653

Food & beverage: $653
CompanyPaymentsAmount
ABBVIE INC.17$279
AstraZeneca Pharmaceuticals LP4$66
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$62
Novo Nordisk Inc3$48
Exact Sciences Corporation2$36
GlaxoSmithKline, LLC.2$34
Otsuka America Pharmaceutical, Inc.2$33
Takeda Pharmaceuticals U.S.A., Inc.1$24
Astellas Pharma US Inc1$23
Lilly USA, LLC1$17

Products named: VRAYLAR, CAPLYTA, Wegovy, Cologuard Collection Kit, TRELEGY ELLIPTA, REXULTI, AIRSUPRA, TRINTELLIX.

Industry payments across IN — which companies pay providers there.